Levodopa/Benserazid Orifarm

Levodopa, the active ingredient in Levodopa/Benserazid Orifarm, is an antiparkinson agent presented as an oral tablet for oral use. It is combined with benserazide to treat Parkinson’s disease by restoring dopamine levels in the central nervous system of adult patients with motor symptoms.

GNH USA supplies Levodopa/Benserazid Orifarm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory compliance, and reliable logistics for the global distribution of this essential Parkinson’s disease therapy through validated supply chains and certified storage conditions.

Levodopa/Benserazide is used in the management of Parkinson’s disease, targeting dopaminergic deficiency.

- Parkinson’s disease: improves motor symptoms such as tremor, rigidity, and bradykinesia. - Parkinsonian syndrome: provides symptomatic relief when dopamine deficiency is present. - Levodopa‑responsive dystonia: reduces dystonic movements in patients who respond to levodopa therapy.

Levodopa/Benserazide may cause a range of adverse reactions.

Common Side Effects: - Nausea: gastrointestinal discomfort often occurring after dose initiation. - Orthostatic hypotension: dizziness or light‑headedness upon standing. - Headache: mild to moderate intensity. - Insomnia: difficulty initiating or maintaining sleep. - Dyspepsia: indigestion or abdominal discomfort. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Dyskinesia: involuntary, erratic movements that may become disabling. - Hallucinations or psychosis: visual or auditory disturbances, especially in older patients. - Severe hypotension: marked blood pressure drop leading to fainting. - Cardiac arrhythmias: irregular heart rhythms requiring monitoring. - Neuroleptic malignant syndrome: rare but life‑threatening reaction when combined with antipsychotics.

When prescribing Levodopa/Benserazide, clinicians should consider several safety measures.

- Monitor blood pressure: watch for orthostatic hypotension, especially during dose titration. - Assess psychiatric status: be alert for hallucinations, confusion, or mood changes. - Adjust dose in renal impairment: reduced clearance may increase systemic exposure. - Avoid abrupt discontinuation: sudden withdrawal can worsen Parkinsonian symptoms. - Use during pregnancy only if clearly needed: limited data on fetal safety. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Levodopa/Benserazide can interact with several medication classes.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: risk of hypertensive crisis. - Antipsychotics (e.g., haloperidol): may diminish antiparkinson efficacy. - Antihypertensive agents: can exacerbate orthostatic hypotension.

Moderate Interactions (Monitor Closely): - SSRIs or SNRIs: may increase serotonin syndrome risk. - Iron or calcium supplements: reduce levodopa absorption. - High‑protein meals: compete with levodopa for intestinal transport, decreasing bioavailability.